RE-BVS – Piemonte Repository

Sfoglia per AUTORE
VANNUCCHI AM
Collezione AOU Alessandria

Items : 6

Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia. in Blood advances / Blood Adv. 2026 May 26;10(10):3494-3504. doi: 10.1182/bloodadvances.2025017575.

2026
AOU Alessandria

Gill H; Palandri F; Ross DM; Göthert JR; Cochrane T; Larsen SR; Halpern AB; Shortt J; Rossetti JM; Liang J; Marchetti M; Wilson AJ; Innes AJ; Hanna M; Vianelli N; Stevenson WS; Vannucchi AM; Kleppe M; Flynn J; Natsoulis G; Harrison CN; Rienhoff HY Jr;

The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study. in Blood advances / Blood Adv. 2026 Jul 14;10(13):4585-4594. doi: 10.1182/bloodadvances.2025018141.

2026
AOU Alessandria

Gill H; Yacoub A; Gerds AT; Shortt J; Rossetti JM; Mead AJ; Göthert JR; Koschmieder S; Ewing J; Halpern AB; Palandri F; Passamonti F; Mesa R; Marchetti M; Harrison C; Vannucchi AM; Watts JM; Wood JC; Ross DM; Peppe J; Natsoulis G; Rienhoff HY Jr;

A Novel, Ruxolitinib-Sensitive, CCDC6::JAK2 Fusion Gene in a Patient With Atypical, JAK2 Unmutated, Polycythemia Vera-Like, Myeloproliferative Neoplasm. in American journal of hematology / Am J Hematol. 2026 Feb;101(2):379-383. doi: 10.1002/ajh.70156. Epub 2025 Dec 3.

2026
AOU Alessandria

Guglielmelli P; Marchetti M; Pelo E; Abbassi Y; Boldrini V; Balliu M; Parrini D; Santi R; Colazzo D; Enderti A; Loscocco GG; Tarantino D; Bartalucci N; Vannucchi AM;

Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design. in Annals of hematology / Ann Hematol. 2025 Jul;104(7):3553-3566. doi: 10.1007/s00277-025-06466-z. Epub 2025 Jul 18.

2025
AOU Alessandria

De Stefano V; Passamonti F; Palandri F; Ramundo F; Rossi E; Betti S; Fagiolo L; Guglielmelli P; Abagnale DP; Pugliese N; Cattaneo D; Iurlo A; Branzanti F; Dedola A; Catellani H; Tieghi A; Basso M; Calistri E; Elli EM; Masselli E; Morsia E; Benevolo G; Breccia M; de Fazio V; Di Perna M; Marchetti M; Santoro M; Tafuri A; Castiglioni C; et alii...

Health-related quality of life and symptom profile of patients with BCR::ABL1-negative myeloproliferative neoplasms: Real-world evidence from the GIMEMA-PROPHECY observational study. in HemaSphere / Hemasphere. 2025 Dec 28;9(12):e70274. doi: 10.1002/hem3.70274. eCollection 2025 Dec.

2025
AOU Alessandria

Caocci G; Costa A; Palandri F; Guglielmelli P; Patriarca A; Iurlo A; Tieghi A; Abruzzese E; Baldi T; Rossi E; Beggiato E; Marchetti M; Fava C; Tomassetti S; Rumi E; Fozza C; Luppi M; Pane F; Bigliardi S; Breccia M; Elli EM; Tartaglia F; Mulas O; Fazi P; Vignetti M; Vannucchi AM; Efficace F;

Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations. in The Lancet. Haematology / Lancet Haematol. 2022 Apr;9(4):e301-e311. doi: 10.1016/S2352-3026(22)00046-1.

2022
AOU Alessandria

Marchetti M; Vannucchi AM; Griesshammer M; Harrison C; Koschmieder S; Gisslinger H; Álvarez-Larrán A; De Stefano V; Guglielmelli P; Palandri F; Passamonti F; Barosi G; Silver RT; Hehlmann R; Kiladjian JJ; Barbui T;